Literature DB >> 30061277

Extensive Genetic Commonality among Wildlife, Wastewater, Community, and Nosocomial Isolates of Escherichia coli Sequence Type 131 (H30R1 and H30Rx Subclones) That Carry blaCTX-M-27 or blaCTX-M-15.

Ivana Jamborova1,2, Brian D Johnston3, Ivo Papousek4,2, Katerina Kachlikova4, Lenka Micenkova5,6, Connie Clabots3, Anna Skalova7,8, Katerina Chudejova7,8, Monika Dolejska4,2, Ivan Literak4,2, James R Johnson3.   

Abstract

Escherichia coli sequence type 131 (ST131) is currently one of the leading causes of multidrug-resistant extraintestinal infections globally. Here, we analyzed the phenotypic and genotypic characteristics of 169 ST131 isolates from various sources (wildlife, wastewater, companion animals, community, and hospitals) to determine whether wildlife and the environment share similar strains with humans, supporting transmission of ST131 between different ecological niches. Susceptibility to 32 antimicrobials was tested by disc diffusion and broth microdilution. Antibiotic resistance genes, integrons, plasmid replicons, 52 virulence genes, and fimH-based subtypes were detected by PCR and DNA sequencing. Genomic relatedness was determined by pulsed-field gel electrophoresis (PFGE). The genetic context and plasmid versus chromosomal location of extended-spectrum beta-lactamase and AmpC beta-lactamase genes was determined by PCR and probe hybridization, respectively. The 169 ST131 study isolates segregated predominantly into blaCTX-M-15H30Rx (60%) and blaCTX-M-27H30R1 (25%) subclones. Within each subclone, isolates from different source groups were categorized into distinct PFGE clusters; genotypic characteristics were fairly well conserved within each major PFGE cluster. Irrespective of source, the blaCTX-M-15H30Rx isolates typically exhibited virotype A (89%), an F2:A1:B- replicon (84%), and a 1.7-kb class 1 integron (92%) and had diverse structures upstream of the blaCTX-M region. In contrast, the blaCTX-M-27H30R1 isolates typically exhibited virotype C (86%), an F1:A2:B20 replicon (76%), and a conserved IS26-ΔISEcp1-blaCTX-M-like structure. Despite considerable overall genetic diversity, our data demonstrate significant commonality between E. coli ST131 isolates from diverse environments, supporting transmission between different sources, including humans, environment, and wildlife.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  ESBL; Escherichia coli ST131; environment; nosocomial and community-acquired infections; virulence; wildlife

Mesh:

Substances:

Year:  2018        PMID: 30061277      PMCID: PMC6153832          DOI: 10.1128/AAC.00519-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

1.  Characterization of human uropathogenic ESBL-producing Escherichia coli in the Czech Republic: spread of CTX-M-27-producing strains in a university hospital.

Authors:  Lenka Micenková; Petra Sišková; Juraj Bosák; Ivana Jamborová; Lenka Cernohorská; David Smajs
Journal:  Microb Drug Resist       Date:  2014-12       Impact factor: 3.431

2.  CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.

Authors:  Yasufumi Matsumura; James R Johnson; Masaki Yamamoto; Miki Nagao; Michio Tanaka; Shunji Takakura; Satoshi Ichiyama
Journal:  J Antimicrob Chemother       Date:  2015-02-16       Impact factor: 5.790

3.  Distribution of virulence factors in ESBL-producing Escherichia coli isolated from the environment, livestock, food and humans.

Authors:  Andrea Müller; Roger Stephan; Magdalena Nüesch-Inderbinen
Journal:  Sci Total Environ       Date:  2015-10-02       Impact factor: 7.963

Review 4.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

6.  Plasmid-mediated resistance to cephalosporins and fluoroquinolones in various Escherichia coli sequence types isolated from rooks wintering in Europe.

Authors:  Ivana Jamborova; Monika Dolejska; Jiri Vojtech; Sebastian Guenther; Raluca Uricariu; Joanna Drozdowska; Ivo Papousek; Katerina Pasekova; Wlodzimierz Meissner; Jozef Hordowski; Alois Cizek; Ivan Literak
Journal:  Appl Environ Microbiol       Date:  2014-11-07       Impact factor: 4.792

7.  Host Characteristics and Bacterial Traits Predict Experimental Virulence for Escherichia coli Bloodstream Isolates From Patients With Urosepsis.

Authors:  James R Johnson; Stephen Porter; Brian Johnston; Michael A Kuskowski; Rachel R Spurbeck; Harry L T Mobley; Deborah A Williamson
Journal:  Open Forum Infect Dis       Date:  2015-06-06       Impact factor: 3.835

8.  Prevalence and characteristics of Escherichia coli sequence type 131 and its H30 and H30Rx subclones: a multicenter study from Korea.

Authors:  Soo-Young Kim; Yeon-Joon Park; James R Johnson; Jin Kyung Yu; Yong-Kyun Kim; Yeong Sic Kim
Journal:  Diagn Microbiol Infect Dis       Date:  2015-10-28       Impact factor: 2.803

9.  Household Clustering of Escherichia coli Sequence Type 131 Clinical and Fecal Isolates According to Whole Genome Sequence Analysis.

Authors:  James R Johnson; Gregg Davis; Connie Clabots; Brian D Johnston; Stephen Porter; Chitrita DebRoy; William Pomputius; Peter T Ender; Michael Cooperstock; Billie Savvas Slater; Ritu Banerjee; Sybille Miller; Dagmara Kisiela; Evgeni V Sokurenko; Maliha Aziz; Lance B Price
Journal:  Open Forum Infect Dis       Date:  2016-06-16       Impact factor: 3.835

10.  Sequential Acquisition of Virulence and Fluoroquinolone Resistance Has Shaped the Evolution of Escherichia coli ST131.

Authors:  Nouri L Ben Zakour; Areej S Alsheikh-Hussain; Melinda M Ashcroft; Nguyen Thi Khanh Nhu; Leah W Roberts; Mitchell Stanton-Cook; Mark A Schembri; Scott A Beatson
Journal:  MBio       Date:  2016-04-26       Impact factor: 7.867

View more
  15 in total

1.  Characterization of bla CTX-M-27/F1:A2:B20 Plasmids Harbored by Escherichia coli Sequence Type 131 Sublineage C1/H30R Isolates Spreading among Elderly Japanese in Nonacute-Care Settings.

Authors:  Nao Matsuo; Rina Nonogaki; Michiko Hayashi; Jun-Ichi Wachino; Masahiro Suzuki; Yoshichika Arakawa; Kumiko Kawamura
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

2.  Antibiotic Resistance of Escherichia coli from Humans and Black Rhinoceroses in Kenya.

Authors:  Kebenei C Kipkorir; Paul O Ang'ienda; David M Onyango; Patrick O Onyango
Journal:  Ecohealth       Date:  2019-12-07       Impact factor: 3.184

3.  Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study.

Authors:  André Birgy; Corinne Levy; Marie-Hélène Nicolas-Chanoine; Aurélie Cointe; Claire A Hobson; Mélanie Magnan; Stéphane Bechet; Philippe Bidet; Robert Cohen; Stéphane Bonacorsi
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

4.  A Comprehensive Account of Escherichia coli Sequence Type 131 in Wastewater Reveals an Abundance of Fluoroquinolone-Resistant Clade A Strains.

Authors:  Thomas J Finn; Lena Scriver; Linh Lam; Mai Duong; Gisele Peirano; Tarah Lynch; Tao Dong; Johann D D Pitout; Rebekah DeVinney
Journal:  Appl Environ Microbiol       Date:  2020-02-03       Impact factor: 4.792

5.  Clinical isolates of Escherichia coli are resistant both to antibiotics and organotin compounds.

Authors:  M Aguilar-Santelises; J Castillo-Vera; R Gonzalez-Molina; A Garcia Del Valle; M Cruz Millan; L Aguilar-Santelises
Journal:  Folia Microbiol (Praha)       Date:  2019-04-17       Impact factor: 2.099

6.  Comparison of approaches for source attribution of ESBL-producing Escherichia coli in Germany.

Authors:  Sara Perestrelo; Guido Correia Carreira; Lars Valentin; Jennie Fischer; Yvonne Pfeifer; Guido Werner; Judith Schmiedel; Linda Falgenhauer; Can Imirzalioglu; Trinad Chakraborty; Annemarie Käsbohrer
Journal:  PLoS One       Date:  2022-07-15       Impact factor: 3.752

7.  Expansion of a Subset Within the C2 Subclade of Escherichia coli Sequence Type 131 (ST131) Is Driving the Increasing Rates of Aminoglycoside Resistance.

Authors:  Zoya Hojabri; Narges Darabi; Majid Mirmohammadkhani; Hamzeh Rahimi; Romina Hemmati; Zahra Saeedi; Kiarash Roustaee; Pimlapas Leekitcharoenphon; Omid Pajand; Frank M Aarestrup
Journal:  Open Forum Infect Dis       Date:  2020-09-08       Impact factor: 3.835

8.  ESBL-Producing Escherichia coli Carrying CTX-M Genes Circulating among Livestock, Dogs, and Wild Mammals in Small-Scale Farms of Central Chile.

Authors:  Julio A Benavides; Marília Salgado-Caxito; Andrés Opazo-Capurro; Paulina González Muñoz; Ana Piñeiro; Macarena Otto Medina; Lina Rivas; Jose Munita; Javier Millán
Journal:  Antibiotics (Basel)       Date:  2021-04-30

9.  Whole-genome analyses of extended-spectrum or AmpC β-lactamase-producing Escherichia coli isolates from companion dogs in Japan.

Authors:  Mayo Yasugi; Shingo Hatoya; Daisuke Motooka; Yuki Matsumoto; Shunsuke Shimamura; Hiroyuki Tani; Masaru Furuya; Keiichiro Mie; Masami Miyake; Shota Nakamura; Terumasa Shimada
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

10.  Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents.

Authors:  Miklos Fuzi; Jesus Rodriguez Baño; Akos Toth
Journal:  Front Microbiol       Date:  2020-02-25       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.